Page last updated: 2024-09-03

isoleucyl-prolyl-arginine-4-nitroanilide and fibrinogen

isoleucyl-prolyl-arginine-4-nitroanilide has been researched along with fibrinogen in 5 studies

Compound Research Comparison

Studies
(isoleucyl-prolyl-arginine-4-nitroanilide)
Trials
(isoleucyl-prolyl-arginine-4-nitroanilide)
Recent Studies (post-2010)
(isoleucyl-prolyl-arginine-4-nitroanilide)
Studies
(fibrinogen)
Trials
(fibrinogen)
Recent Studies (post-2010) (fibrinogen)
230034,4771,7077,083

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's3 (60.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botstein, D; Brady, K; Johnson, AC; Kerr, EM; Nguyen, HV; Paoni, NF; Peña, LC; Refino, CJ; van Reis, R; Wurm, FM1
Collen, D; Li, XK; Lijnen, HR; Nelles, L; Stassen, JM; Van Hoef, B1
Hogg, PJ; Jackson, CM1
Castellino, FJ; deSerrano, VS; Urano, S; Urano, T1
Chmielewska, J; Rånby, M; Wiman, B1

Other Studies

5 other study(ies) available for isoleucyl-prolyl-arginine-4-nitroanilide and fibrinogen

ArticleYear
Involvement of residues 296-299 in the enzymatic activity of tissue-type plasminogen activator.
    Protein engineering, 1992, Volume: 5, Issue:3

    Topics: Alanine; Amino Acid Sequence; Fibrin; Fibrinogen; Fibrinolysis; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligopeptides; Plasma; Plasminogen; Protein Engineering; Tissue Plasminogen Activator

1992
Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1.
    Blood, 1992, Jan-15, Volume: 79, Issue:2

    Topics: Amino Acid Sequence; Animals; Chemical Phenomena; Chemistry, Physical; Chromogenic Compounds; Cricetinae; DNA; Fibrin; Fibrinogen; Fibrinolysis; Gene Expression; Humans; Hydrolysis; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Oligopeptides; Plasminogen; Plasminogen Inactivators; Pulmonary Embolism; Recombinant Proteins; Tissue Plasminogen Activator

1992
Formation of a ternary complex between thrombin, fibrin monomer, and heparin influences the action of thrombin on its substrates.
    The Journal of biological chemistry, 1990, Jan-05, Volume: 265, Issue:1

    Topics: Amino Acid Sequence; Chromogenic Compounds; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Fibrinopeptide B; Heparin; Humans; Hydrogen-Ion Concentration; Hydrolysis; Macromolecular Substances; Molecular Sequence Data; Oligopeptides; Prothrombin; Substrate Specificity; Thrombin

1990
Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
    Archives of biochemistry and biophysics, 1989, Volume: 270, Issue:1

    Topics: Amides; Dose-Response Relationship, Drug; Enzyme Activation; Fibrin; Fibrinogen; Kinetics; Oligopeptides; Recombinant Proteins; Tissue Plasminogen Activator

1989
Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.
    The Biochemical journal, 1988, Apr-15, Volume: 251, Issue:2

    Topics: Binding Sites; Fibrin; Fibrinogen; Glycoproteins; Humans; Isoflurophate; Kinetics; Ligands; Oligopeptides; Plasminogen Activators; Plasminogen Inactivators

1988